Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2020). Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 122(7), p. 1119. Nature Publishing Group 10.1038/s41416-019-0709-x
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
s41416-019-0709-x.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (182kB) |
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Bernhard, Jürg Theodor |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0007-0920 |
Publisher: |
Nature Publishing Group |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
26 May 2020 17:07 |
Last Modified: |
02 Mar 2023 23:33 |
Publisher DOI: |
10.1038/s41416-019-0709-x |
PubMed ID: |
31949268 |
BORIS DOI: |
10.7892/boris.143130 |
URI: |
https://boris.unibe.ch/id/eprint/143130 |
Actions (login required)
 |
Edit item |